Literature DB >> 1686218

Developmental regulation of GAP-43, glutamine synthetase and beta-actin mRNA in rat cortical astrocytes.

A da Cunha1, V J Aloyo, L Vitković.   

Abstract

Steady-state levels of mRNA encoding growth-associated protein 43 (GAP-43), glutamine synthetase (GS) and beta-actin were measured during development of neonatal rat cortical astrocytes in primary culture. GAP-43 mRNA and protein decreased rapidly during the first 2 weeks and slowly thereafter. In contrast, GS mRNA increased approximately 3-fold during the first 2 weeks and reached maximum by day 15. Actin mRNA first increased up to 8 days and decreased thereafter reaching a constant amount of 15 days, similar to the initial low value. Thus, GAP-43, GS and beta-actin mRNA levels are differentially regulated during development of astrocytes in primary culture. Because the patterns of expression of astrocytic markers GS and GFAP (shown previously) in vitro and in vivo are similar to each other, primary cultures of astrocytes may be an excellent system for investigating mechanisms of developmental regulation of these genes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686218     DOI: 10.1016/0165-3806(91)90228-b

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  3 in total

1.  Expression of GAP-43 mRNA in the adult mammalian spinal cord under normal conditions and after different types of lesions, with special reference to motoneurons.

Authors:  H Lindå; F Piehl; A Dagerlind; V M Verge; U Arvidsson; S Cullheim; M Risling; B Ulfhake; T Hökfelt
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

Review 2.  A Shift from a Pivotal to Supporting Role for the Growth-Associated Protein (GAP-43) in the Coordination of Axonal Structural and Functional Plasticity.

Authors:  Matthew R Holahan
Journal:  Front Cell Neurosci       Date:  2017-08-31       Impact factor: 5.505

3.  Heterogeneity of astrocytes: from development to injury - single cell gene expression.

Authors:  Vendula Rusnakova; Pavel Honsa; David Dzamba; Anders Ståhlberg; Mikael Kubista; Miroslava Anderova
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.